ABVC AMER BRIVISION

-

AMER BRIVISION Reported Earnings

Tuesday, November 10, 2026 · 12:00 AM ET

AMER BRIVISION (ABVC) reported a loss of $0.04 per share on revenue of $0.00 million for the . . Revenue fell 100.00% compared to the same quarter a year ago.

ABVC BioPharma Inc. is a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system, ophthalmology and oncology/hematology indications. ABVC BioPharma Inc. is based in SILICON VALLEY, CA.

Earnings Whisper Grade —
Power Rating—
Reported Earnings
($0.04)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth20.0 %
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth-100.0 %